{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:05:45Z","timestamp":1790651145703,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pregnant individuals and infants are at risk from vaccine-preventable diseases like severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza. Maternal vaccination during pregnancy can protect both the mother and child. Recent progress in developing these vaccines is notable, but vaccine hesitancy and the exclusion of pregnant individuals from clinical trials limit their use. Maternal immunization safeguards mothers from severe illness and adverse pregnancy outcomes while providing infants with antibodies through the placenta and breast milk. Inactivated vaccines are generally effective and safe during pregnancy. Limited safety and efficacy data due to exclusion from trials hinder vaccine uptake; however, vaccines like tetanus-diphtheria-acellular pertussis (Tdap), influenza, and SARS-CoV-2 have proven effective, and are recommended vaccines during pregnancy. New vaccines for group B Streptococcus (GBS) and cytomegalovirus are in development, with the GBS vaccine being the most advanced. Combating vaccine hesitancy through strong health care provider recommendations is vital to enhance uptake and protect pregnant individuals and their infants.<\/jats:p>","DOI":"10.1093\/infdis\/jiae509","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T18:29:11Z","timestamp":1729535351000},"page":"830-836","source":"Crossref","is-referenced-by-count":12,"title":["Maternal Immunization"],"prefix":"10.1093","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0990-1350","authenticated-orcid":false,"given":"Hye-Kyung","family":"Cho","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Ewha Womans University Mokdong Hospital , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collrane","family":"Frivold","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington , Seattle, Washington ,","place":["USA"]},{"name":"Department of Epidemiology, University of Washington , Seattle, Washington ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Y","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington , Seattle, Washington ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"2025041514212435900_jiae509-B1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2022.08.038","article-title":"Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis","volume":"228","author":"Smith","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"2025041514212435900_jiae509-B2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1503\/cmaj.061435","article-title":"Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women","volume":"176","author":"Dodds","year":"2007","journal-title":"CMAJ"},{"key":"2025041514212435900_jiae509-B3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0891-5520(05)70278-6","article-title":"Vaccines in pregnancy","volume":"15","author":"Munoz","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"2025041514212435900_jiae509-B4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/cid\/ciu327","article-title":"Maternal immunization","volume":"59","author":"Chu","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025041514212435900_jiae509-B5","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1016\/j.vaccine.2016.04.066","article-title":"Pertussis vaccination during pregnancy in Belgium: follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age","volume":"34","author":"Maertens","year":"2016","journal-title":"Vaccine"},{"key":"2025041514212435900_jiae509-B6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.15585\/mmwr.mm7239a4","article-title":"Influenza, Tdap, and COVID-19 vaccination coverage and hesitancy among pregnant women\u2014United States, April 2023","volume":"72","author":"Razzaghi","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025041514212435900_jiae509-B7","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1016\/j.vaccine.2023.10.057","article-title":"The inclusion of pregnant women in vaccine clinical trials: an overview of late-stage clinical trials\u2019 records between 2018 and 2023","volume":"41","author":"Salloum","year":"2023","journal-title":"Vaccine"},{"key":"2025041514212435900_jiae509-B8","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3389\/fimmu.2017.01294","article-title":"Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy","volume":"8","author":"Wilcox","year":"2017","journal-title":"Front Immunol"},{"key":"2025041514212435900_jiae509-B9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/322808","article-title":"The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population","volume":"184","author":"Okoko","year":"2001","journal-title":"J Infect Dis"},{"key":"2025041514212435900_jiae509-B10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/infdis\/173.5.1077","article-title":"Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection","volume":"173","author":"de Moraes-Pinto","year":"1996","journal-title":"J Infect Dis"},{"key":"2025041514212435900_jiae509-B11","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1016\/j.vaccine.2014.09.052","article-title":"Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines","volume":"32","author":"Keller-Stanislawski","year":"2014","journal-title":"Vaccine"},{"key":"2025041514212435900_jiae509-B12","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1016\/j.vaccine.2023.06.073","article-title":"Exclusion of pregnant people from emergency vaccine clinical trials: a systematic review of clinical trial protocols and reporting from 2009 to 2019","volume":"41","author":"Minchin","year":"2023","journal-title":"Vaccine"},{"key":"2025041514212435900_jiae509-B13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ajog.2022.07.037","article-title":"Scientific, ethical, and legal considerations for the inclusion of pregnant people in clinical trials","volume":"227","author":"Sewell","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"2025041514212435900_jiae509-B14","doi-asserted-by":"crossref","first-page":"e20164091","DOI":"10.1542\/peds.2016-4091","article-title":"Effectiveness of vaccination during pregnancy to prevent infant pertussis","volume":"139","author":"Baxter","year":"2017","journal-title":"Pediatrics"},{"key":"2025041514212435900_jiae509-B15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41467-024-44943-7","article-title":"Maternal pertussis immunization and the blunting of routine vaccine effectiveness: a meta-analysis and modeling study","volume":"15","author":"Briga","year":"2024","journal-title":"Nat Commun"},{"key":"2025041514212435900_jiae509-B16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/14760584.2020.1749597","article-title":"Immune interference (blunting) in the context of maternal immunization with Tdap-containing vaccines: is it a class effect?","volume":"19","author":"Kandeil","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"2025041514212435900_jiae509-B17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.vaccine.2016.12.012","article-title":"Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies","volume":"35","author":"Mertz","year":"2017","journal-title":"Vaccine"},{"key":"2025041514212435900_jiae509-B18","doi-asserted-by":"crossref","first-page":"e20172918","DOI":"10.1542\/peds.2017-2918","article-title":"Influenza-associated pediatric deaths in the United States, 2010-2016","volume":"141","author":"Shang","year":"2018","journal-title":"Pediatrics"},{"key":"2025041514212435900_jiae509-B19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/1471-0528.14143","article-title":"Maternal influenza and birth outcomes: systematic review of comparative studies","volume":"124","author":"Fell","year":"2017","journal-title":"BJOG"},{"key":"2025041514212435900_jiae509-B20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJM200001273420402","article-title":"Influenza and the rates of hospitalization for respiratory disease among infants and young children","volume":"342","author":"Izurieta","year":"2000","journal-title":"N Engl J Med"},{"key":"2025041514212435900_jiae509-B21","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants","volume":"359","author":"Zaman","year":"2008","journal-title":"N Engl J Med"},{"key":"2025041514212435900_jiae509-B22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1503\/cmaj.110754","article-title":"Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial","volume":"184","author":"Steinhoff","year":"2012","journal-title":"CMAJ"},{"key":"2025041514212435900_jiae509-B23","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S1473-3099(16)30054-8","article-title":"Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2025041514212435900_jiae509-B24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa1401480","article-title":"Influenza vaccination of pregnant women and protection of their infants","volume":"371","author":"Madhi","year":"2014","journal-title":"N Engl J Med"},{"key":"2025041514212435900_jiae509-B25","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1473-3099(17)30252-9","article-title":"Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial","volume":"17","author":"Steinhoff","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2025041514212435900_jiae509-B26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/jamapediatrics.2023.5639","article-title":"Maternal vaccine effectiveness against influenza-associated hospitalizations and emergency department visits in infants","volume":"178","author":"Sahni","year":"2024","journal-title":"JAMA Pediatr"},{"key":"2025041514212435900_jiae509-B27","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.15585\/mmwr.mm7239a3","article-title":"Overcoming COVID-19 investigators. Effectiveness of maternal mRNA COVID-19 vaccination during pregnancy against COVID-19-associated hospitalizations in infants aged &lt;6 months during SARS-CoV-2 Omicron predominance\u201420 states, March 9, 2022-May 31, 2023","volume":"72","author":"Simeone","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025041514212435900_jiae509-B28","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1038\/s41467-024-46694-x","article-title":"Maternal hybrid immunity and risk of infant COVID-19 hospitalizations: national case-control study in Israel","volume":"15","author":"Guedalia","year":"2024","journal-title":"Nat Commun"},{"key":"2025041514212435900_jiae509-B29","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/infdis\/jiz338","article-title":"Protective efficacy of nucleic acid vaccines against transmission of Zika virus during pregnancy in mice","volume":"220","author":"Jagger","year":"2019","journal-title":"J Infect Dis"},{"key":"2025041514212435900_jiae509-B30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.vaccine.2016.11.040","article-title":"Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens","volume":"35","author":"Maruggi","year":"2017","journal-title":"Vaccine"},{"key":"2025041514212435900_jiae509-B31","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1016\/j.vaccine.2020.09.079","article-title":"Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine","volume":"38","author":"LaTourette II","year":"2020","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"2025041514212435900_jiae509-B32","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/infdis\/jiac120","article-title":"Respiratory syncytial virus is the leading cause of United States infant hospitalizations, 2009-2019: a study of the national (nationwide) inpatient sample","volume":"226","author":"Suh","year":"2022","journal-title":"J Infect Dis"},{"key":"2025041514212435900_jiae509-B33","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"key":"2025041514212435900_jiae509-B34","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa2305478","article-title":"RSV prefusion F protein-based maternal vaccine\u2014preterm birth and other outcomes","volume":"390","author":"Dieussaert","year":"2024","journal-title":"N Engl J Med"},{"key":"2025041514212435900_jiae509-B35","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.15585\/mmwr.mm7241e1","article-title":"Use of the Pfizer respiratory syncytial virus vaccine during pregnancy for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in infants: recommendations of the advisory committee on immunization practices\u2014United States, 2023","volume":"72","author":"Fleming-Dutra","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025041514212435900_jiae509-B36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa2116045","article-title":"Potential for maternally administered vaccine for infant group B streptococcus","volume":"389","author":"Madhi","year":"2023","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"2025041514212435900_jiae509-B37","doi-asserted-by":"crossref","first-page":"ofad500-2475","DOI":"10.1093\/ofid\/ofad500.2475","article-title":"2892. Safety and immunogenicity of mRNA-1647, an mRNA-based cytomegalovirus vaccine in healthy adults: results of a phase 2, randomized, observer-blind, placebo-controlled, dose-finding trial","volume":"10","author":"Panther","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025041514212435900_jiae509-B38","doi-asserted-by":"crossref","first-page":"103685","DOI":"10.1016\/j.jri.2022.103685","article-title":"Anti-SARS-CoV-2 antibodies in breast milk during lactation after infection or vaccination: a cohort study","volume":"153","author":"Olearo","year":"2022","journal-title":"J Reprod Immunol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae509\/60205024\/jiae509.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/4\/830\/60205024\/jiae509.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/4\/830\/60205024\/jiae509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T14:51:43Z","timestamp":1744728703000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/231\/4\/830\/7829167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,10,21]]},"published-print":{"date-parts":[[2025,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae509","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4,15]]},"published":{"date-parts":[[2024,10,21]]}}}